⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
企業紛紛採用Boomi人工智慧啟用平台作為標準，推動市場動能加速增長
businesswire.com
CVLG
SNOW
IBM
MSFT
GOOG
AMZN
CRM
ORCL
SAP
INTC
CSCO
ACN
DXC
WNS
INFY
NTAP
CDNS
SNPS
PANW
OKTA
DDOG
SMCI
NVDA
AMD
QCOM
AVGO
MU
AMAT
KLAC
LRCX
ADI
TXN
MCHP
NXPI
ON
AEHR
TER
ASML
ENPH
SEDG
PLUG
FCEL
BLNK
RIVN
LCID
TSLA
GM
F
STLA
GE
HON
BA
LMT
GD
RTX
NOC
MMM
DOW
DD
ECL
IFF
LIN
ALGN
BIIB
GILD
AMGN
REGN
VRTX
BMY
PFE
MRK
JNJ
ABBV
LLY
MDT
ISRG
EW
ABT
SYK
DHR
CI
UNH
CVS
MCK
CAH
GOOGL
beHuman Raises $4 Million Seed Round to Expand Equitable, AI-Driven Early Cancer Detection Nationwide
prnewswire.com
BMY
IBM
BDX
BSX
JNJ
OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb
globenewswire.com
BMY
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi
businesswire.com
BMY
Clinical Trials Support Service Market to Reach US$ 47.1 Billion by 2032 Driven by Rising Trial Complexity, Patient-Centric Models, and AI-Based Trial Management | Astute Analytica
globenewswire.com
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
LLY
ABBV
AZN
In-Vitro Toxicology Testing Market to Reach US$ 57.55 Billion by 2033 Supported by OECD Guidelines, EPA NAM Framework, and EU Cosmetics Regulation Says Astute Analytica
globenewswire.com
CRL
AMGN
BMY
MRK
PFE
JNJ
Independent Multi-Vendor Study Validates BostonGene’s AI for Precision HER2 Scoring
businesswire.com
AZN
BMY
AMGN
MRK
GSK
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
businesswire.com
BMY
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
globenewswire.com
NVS
JNJ
VRTX
BMY
JAZZ